Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 14-Nov-24 5:30 PM View:  | Loscalzo Joseph Director | ISIS Pharmaceuticals Inc. (IONS) | 12-Nov-24 | Private Sale (Planned) | 13,508 | $37.86 | $511,426.00 | (30%) 45.76K to 32.25K | |
| 14-Nov-24 5:30 PM View: | Monia Brett P Chief Executive Officer Director | ISIS Pharmaceuticals Inc. (IONS) | 12-Nov-24 | Private Sale (Planned) | 6,630 | $38.05 | $252,294.00 | (4%) 174.02K to 167.39K | |
| 14-Nov-24 5:30 PM View: | Swayze Eric EVP Research | ISIS Pharmaceuticals Inc. (IONS) | 12-Nov-24 | Private Sale (Planned) | 1,194 | $37.92 | $45,277.70 | (3%) 35.06K to 33.87K | |
| 04-Sep-24 9:43 PM View: | O'Neil Patrick R. EVP CLO & General Counsel | ISIS Pharmaceuticals Inc. (IONS) | 30-Aug-24 | Acquisition (other) | 246 | $38.64 | $9,505.69 | < 1% 48.63K to 48.87K | |
| 04-Sep-24 9:40 PM View: | Birchler Brian EVP, Corp and Development Ops | ISIS Pharmaceuticals Inc. (IONS) | 30-Aug-24 | Acquisition (other) | 12 | $38.64 | $463.69 | < 1% 46.16K to 46.17K | |
| 04-Sep-24 9:41 PM View: | Geary Richard S EVP, Chief Development Officer | ISIS Pharmaceuticals Inc. (IONS) | 30-Aug-24 | Acquisition (other) | 11 | $38.64 | $425.05 | < 1% 84.82K to 84.83K | |
| 04-Sep-24 9:40 PM View: | Bennett C Frank EVP, Chief Scientific Officer | ISIS Pharmaceuticals Inc. (IONS) | 30-Aug-24 | Acquisition (other) | 177 | $38.64 | $6,839.46 | < 1% 79.43K to 79.61K | |
| 03-Sep-24 7:18 PM View: | Geary Richard S EVP, Chief Development Officer | ISIS Pharmaceuticals Inc. (IONS) | 29-Aug-24 | Sale (Planned) | 331 | $49.63 | $16,427.50 | (< 1%) 85.15K to 84.82K | |
| 03-Sep-24 7:18 PM View: | Geary Richard S EVP, Chief Development Officer | ISIS Pharmaceuticals Inc. (IONS) | 28-Aug-24 | Private Sale (Planned) | 320 | $49.16 | $15,731.20 | (< 1%) 85.47K to 85.15K | |
| 06-Aug-24 5:27 PM View: | Geary Richard S EVP, Chief Development Officer | ISIS Pharmaceuticals Inc. (IONS) | 05-Aug-24 | Private Sale (Planned) | 2,430 | $48.00 | $116,640.00 | (3%) 87.94K to 85.51K | |
| 17-Jul-24 5:02 PM View: | Klein Joseph III Director | ISIS Pharmaceuticals Inc. (IONS) | 16-Jul-24 | Option Exercise | 12,000 | $24.42 | $293,040.00 | 73% 16.45K to 28.45K | |
| 17-Jul-24 5:02 PM View: | Klein Joseph III Director | ISIS Pharmaceuticals Inc. (IONS) | 16-Jul-24 | Planned Option Sale | 12,000 | $50.00 | $600,000.00 | (42%) 28.45K to 16.45K | |
| 17-Jul-24 5:02 PM View: | Diaz Allene M. Director | ISIS Pharmaceuticals Inc. (IONS) | 16-Jul-24 | Planned Option Sale | 1,637 | $49.49 | $81,019.40 | (9%) 17.35K to 15.72K | |
| 17-Jul-24 5:03 PM View: | Wender Joseph H Director | ISIS Pharmaceuticals Inc. (IONS) | 15-Jul-24 | Option Exercise Duplicate | 4,677 | -- | -- | 4% 128.08K to 132.76K | |
| 17-Jul-24 5:02 PM View: | Diaz Allene M. Director | ISIS Pharmaceuticals Inc. (IONS) | 15-Jul-24 | Option Exercise | 4,677 | -- | -- | 37% 12.68K to 17.35K | |
| 17-Jul-24 5:03 PM View: | Parshall B Lynne Director | ISIS Pharmaceuticals Inc. (IONS) | 15-Jul-24 | Option Exercise | 4,677 | -- | -- | 6% 82.59K to 87.27K | |
| 17-Jul-24 5:02 PM View: | Herman Joan E Director | ISIS Pharmaceuticals Inc. (IONS) | 15-Jul-24 | Option Exercise | 4,677 | -- | -- | 13% 37.33K to 42.01K | |
| 17-Jul-24 5:03 PM View: | Loscalzo Joseph Director | ISIS Pharmaceuticals Inc. (IONS) | 15-Jul-24 | Option Exercise | 4,677 | -- | -- | 11% 41.08K to 45.76K | |
| 17-Jul-24 5:02 PM View: | Berthelsen Spencer R Director | ISIS Pharmaceuticals Inc. (IONS) | 15-Jul-24 | Option Exercise | 4,677 | -- | -- | 3% 147.33K to 152.0K | |
| 20-Jun-24 5:52 PM View: | Berthelsen Spencer R Director | ISIS Pharmaceuticals Inc. (IONS) | 17-Jun-24 | Option Sale | 16,000 | $40.29 | $644,640.00 | (10%) 163.33K to 147.33K | |
| 20-Jun-24 5:52 PM View: | Berthelsen Spencer R Director | ISIS Pharmaceuticals Inc. (IONS) | 17-Jun-24 | Option Exercise | 16,000 | $35.53 | $568,480.00 | 11% 147.33K to 163.33K | |
| 13-May-24 5:25 PM View: | Wender Joseph H Director | ISIS Pharmaceuticals Inc. (IONS) | 09-May-24 | Option Exercise | 16,000 | $35.53 | $568,480.00 | 14% 112.08K to 128.08K | |
| 07-May-24 4:55 PM View: | Klein Joseph III Director | ISIS Pharmaceuticals Inc. (IONS) | 03-May-24 | Private Sale | 6,000 | $42.71 | $256,277.00 | (27%) 22.45K to 16.45K | |
| 17-Apr-24 5:19 PM View: | Baroldi Joseph EVP, Chief Business Officer | ISIS Pharmaceuticals Inc. (IONS) | 16-Apr-24 | Option Sale | 4,006 | $41.60 | $166,641.00 | (16%) 25.28K to 21.27K | |
| 17-Apr-24 5:16 PM View: | Birchler Brian EVP, Corp and Development Ops | ISIS Pharmaceuticals Inc. (IONS) | 16-Apr-24 | Option Sale | 905 | $41.66 | $37,698.20 | (2%) 47.06K to 46.16K | |
| 17-Apr-24 5:19 PM View: | Baroldi Joseph EVP, Chief Business Officer | ISIS Pharmaceuticals Inc. (IONS) | 15-Apr-24 | Option Exercise | 10,838 | -- | -- | 75% 14.44K to 25.28K | |
| 17-Apr-24 5:16 PM View: | Birchler Brian EVP, Corp and Development Ops | ISIS Pharmaceuticals Inc. (IONS) | 15-Apr-24 | Option Exercise | 1,875 | -- | -- | 4% 45.19K to 47.06K | |
| 04-Mar-24 7:13 PM View: | Bennett C Frank Officer Level 14 | ISIS Pharmaceuticals Inc. (IONS) | 29-Feb-24 | Acquisition (other) | 383 | $34.42 | $13,184.80 | < 1% 79.08K to 79.46K | |
| 04-Mar-24 7:13 PM View: | Monia Brett P CEO Level 15 Director | ISIS Pharmaceuticals Inc. (IONS) | 29-Feb-24 | Acquisition (other) | 538 | $34.42 | $18,520.70 | < 1% 173.75K to 174.29K | |
| 04-Mar-24 7:13 PM View: | Birchler Brian Vice President Level 14 | ISIS Pharmaceuticals Inc. (IONS) | 29-Feb-24 | Acquisition (other) | 604 | $34.42 | $20,792.70 | 1% 44.58K to 45.19K | |
| 04-Mar-24 7:13 PM View: | Swayze Eric Officer Level 14 | ISIS Pharmaceuticals Inc. (IONS) | 29-Feb-24 | Acquisition (other) | 605 | $34.42 | $20,827.10 | 2% 34.41K to 35.01K | |
| 04-Mar-24 7:13 PM View: | Geary Richard S Officer Level 14 | ISIS Pharmaceuticals Inc. (IONS) | 29-Feb-24 | Acquisition (other) | 604 | $34.42 | $20,792.70 | < 1% 87.33K to 87.94K | |
| 16-Feb-24 7:47 PM View: | Monia Brett P Chief Executive Officer Director | ISIS Pharmaceuticals Inc. (IONS) | 16-Feb-24 | Private Sale | 387 | $44.49 | $17,218.60 | (< 1%) 174.14K to 173.75K | |
| 02-Feb-24 7:54 PM View: | Geary Richard S EVP, Chief Development Officer | ISIS Pharmaceuticals Inc. (IONS) | 02-Feb-24 | Sale | 1,961 | $50.04 | $98,134.90 | (2%) 89.3K to 87.33K | |
| 02-Feb-24 7:54 PM View: | Bennett C Frank EVP, Chief Scientific Officer | ISIS Pharmaceuticals Inc. (IONS) | 02-Feb-24 | Sale | 1,853 | $49.52 | $91,752.40 | (2%) 80.93K to 79.08K | |
| 02-Feb-24 7:55 PM View: | Hougen Elizabeth L EVP, Finance & CFO | ISIS Pharmaceuticals Inc. (IONS) | 02-Feb-24 | Sale | 2,125 | $49.54 | $105,272.00 | (2%) 95.03K to 92.91K | |
| 02-Feb-24 7:55 PM View: | Schneider Eugene EVP, Chf Clinical Develop Ofcr | ISIS Pharmaceuticals Inc. (IONS) | 02-Feb-24 | Sale | 2,071 | $49.59 | $102,701.00 | (4%) 51.88K to 49.81K | |
| 02-Feb-24 7:55 PM View: | Swayze Eric EVP Research | ISIS Pharmaceuticals Inc. (IONS) | 02-Feb-24 | Sale | 1,907 | $49.56 | $94,513.40 | (5%) 36.32K to 34.41K | |
| 02-Feb-24 7:55 PM View: | Monia Brett P Chief Executive Officer Director | ISIS Pharmaceuticals Inc. (IONS) | 02-Feb-24 | Sale | 23,501 | $49.37 | $1,160,300.00 | (12%) 197.64K to 174.14K | |
| 02-Feb-24 7:55 PM View: | O'Neil Patrick R. EVP CLO & General Counsel | ISIS Pharmaceuticals Inc. (IONS) | 02-Feb-24 | Sale | 1,961 | $49.67 | $97,410.30 | (4%) 50.62K to 48.66K | |
| 02-Feb-24 7:54 PM View: | Cadoret-Manier Onaiza EVP,Chf GL Pdt Str & Oper Ofc | ISIS Pharmaceuticals Inc. (IONS) | 02-Feb-24 | Sale | 2,125 | $49.60 | $105,404.00 | (6%) 37.95K to 35.83K | |
| 02-Feb-24 7:55 PM View: | Schneider Eugene EVP, Chf Clinical Develop Ofcr | ISIS Pharmaceuticals Inc. (IONS) | 01-Feb-24 | Grant | 4,033 | -- | -- | 8% 47.85K to 51.88K | |
| 02-Feb-24 7:55 PM View: | Monia Brett P Chief Executive Officer Director | ISIS Pharmaceuticals Inc. (IONS) | 01-Feb-24 | Grant | 45,788 | -- | -- | 30% 151.85K to 197.64K | |
| 02-Feb-24 7:54 PM View: | Geary Richard S EVP, Chief Development Officer | ISIS Pharmaceuticals Inc. (IONS) | 01-Feb-24 | Grant | 3,820 | -- | -- | 4% 85.47K to 89.3K | |
| 02-Feb-24 7:54 PM View: | Bennett C Frank EVP, Chief Scientific Officer | ISIS Pharmaceuticals Inc. (IONS) | 01-Feb-24 | Grant | 3,609 | -- | -- | 5% 77.32K to 80.93K | |
| 02-Feb-24 7:55 PM View: | O'Neil Patrick R. EVP CLO & General Counsel | ISIS Pharmaceuticals Inc. (IONS) | 01-Feb-24 | Grant | 3,820 | -- | -- | 8% 46.8K to 50.62K | |
| 02-Feb-24 7:55 PM View: | Hougen Elizabeth L EVP, Finance & CFO | ISIS Pharmaceuticals Inc. (IONS) | 01-Feb-24 | Grant | 4,140 | -- | -- | 5% 90.89K to 95.03K | |
| 02-Feb-24 7:55 PM View: | Swayze Eric EVP Research | ISIS Pharmaceuticals Inc. (IONS) | 01-Feb-24 | Grant | 3,715 | -- | -- | 11% 32.6K to 36.32K | |
| 02-Feb-24 7:54 PM View: | Cadoret-Manier Onaiza EVP, Chf GL Pdt Str & Oper Ofc | ISIS Pharmaceuticals Inc. (IONS) | 01-Feb-24 | Grant | 4,140 | -- | -- | 12% 33.81K to 37.95K | |
| 02-Feb-24 7:55 PM View: | Swayze Eric EVP Research | ISIS Pharmaceuticals Inc. (IONS) | 31-Jan-24 | Private Sale | 10,773 | $52.00 | $560,196.00 | (25%) 43.37K to 32.6K |
